VISIPAQUE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Visipaque, and what generic alternatives are available?
Visipaque is a drug marketed by Ge Healthcare and is included in two NDAs.
The generic ingredient in VISIPAQUE is iodixanol. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iodixanol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Visipaque
A generic version of VISIPAQUE was approved as iodixanol by HENGRUI PHARMA on May 19th, 2022.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VISIPAQUE?
- What are the global sales for VISIPAQUE?
- What is Average Wholesale Price for VISIPAQUE?
Summary for VISIPAQUE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for VISIPAQUE |
| What excipients (inactive ingredients) are in VISIPAQUE? | VISIPAQUE excipients list |
| DailyMed Link: | VISIPAQUE at DailyMed |
US Patents and Regulatory Information for VISIPAQUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020808-002 | Aug 29, 1997 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020808-001 | Aug 29, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
